DEVELOPMENT OF PERSONALIZED CANCER VACCINES TARGETING TUMOR HETEROGENEITY AND REPROGRAMMING THE COLD TUMOR MICRO-ENVIRONMENT IN KIDNEY CANCER

The General Hospital Corporation

Investigators